- Report
- January 2026
- 192 Pages
Global
From €3171EUR$3,545USD£2,745GBP
€3524EUR$3,939USD£3,051GBP
- Report
- March 2026
- 189 Pages
Global
From €5233EUR$5,850USD£4,530GBP
- Report
- February 2026
- 250 Pages
Global
From €4016EUR$4,490USD£3,477GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1789EUR$2,000USD£1,549GBP
- Report
- March 2025
- 185 Pages
Global
From €4025EUR$4,500USD£3,485GBP
- Report
- June 2025
- 150 Pages
Global
From €2414EUR$2,699USD£2,090GBP
- Report
- July 2025
- 205 Pages
Global
From €2236EUR$2,500USD£1,936GBP
- Report
- November 2025
- 160 Pages
Global
From €3003EUR$3,358USD£2,600GBP
€3533EUR$3,950USD£3,059GBP
- Report
- May 2025
- 92 Pages
Global
From €3500EUR$4,191USD£3,136GBP
- Report
- February 2026
Global
From €4383EUR$4,900USD£3,795GBP
- Report
- February 2026
- 250 Pages
Global
From €4016EUR$4,490USD£3,477GBP
- Report
- February 2026
- 250 Pages
Global
From €4016EUR$4,490USD£3,477GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1789EUR$2,000USD£1,549GBP
- Drug Pipelines
- June 2025
- 200 Pages
Global
From €2495EUR$2,789USD£2,160GBP
- Report
- February 2026
- 135 Pages
Global
From €3577EUR$3,999USD£3,097GBP
- Report
- January 2026
- 169 Pages
Global
From €4160EUR$4,650USD£3,601GBP
- Report
- January 2026
- 186 Pages
Global
From €3171EUR$3,545USD£2,745GBP
€3524EUR$3,939USD£3,051GBP
- Report
- January 2026
- 180 Pages
Global
From €3171EUR$3,545USD£2,745GBP
€3524EUR$3,939USD£3,051GBP
- Report
- August 2025
- 198 Pages
Global
From €3171EUR$3,545USD£2,745GBP
€3524EUR$3,939USD£3,051GBP
- Report
- June 2025
- 233 Pages
Global
From €2236EUR$2,500USD£1,936GBP

The Insomnia Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Insomnia drugs are used to treat difficulty sleeping, and can be divided into two categories: sedative-hypnotics and non-sedative hypnotics. Sedative-hypnotics are drugs that act on the central nervous system to induce sleep, while non-sedative hypnotics are drugs that act on the brain to improve sleep quality without causing sedation. Commonly prescribed insomnia drugs include benzodiazepines, non-benzodiazepines, and melatonin receptor agonists.
Some companies in the Insomnia Drug market include Sanofi, Pfizer, Merck, GlaxoSmithKline, and Takeda. Show Less Read more